company background image
4569 logo

KYORIN Pharmaceutical TSE:4569 Stock Report

Last Price

JP¥1.45k

Market Cap

JP¥83.1b

7D

-0.4%

1Y

-18.2%

Updated

22 Dec, 2024

Data

Company Financials +

KYORIN Pharmaceutical Co., Ltd.

TSE:4569 Stock Report

Market Cap: JP¥83.1b

4569 Stock Overview

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally. More details

4569 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

KYORIN Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for KYORIN Pharmaceutical
Historical stock prices
Current Share PriceJP¥1,447.00
52 Week HighJP¥1,880.00
52 Week LowJP¥1,438.00
Beta-0.097
1 Month Change-3.47%
3 Month Change-3.85%
1 Year Change-18.16%
3 Year Change-20.10%
5 Year Change-24.95%
Change since IPO-2.16%

Recent News & Updates

KYORIN Pharmaceutical's (TSE:4569) Soft Earnings Are Actually Better Than They Appear

Nov 14
KYORIN Pharmaceutical's (TSE:4569) Soft Earnings Are Actually Better Than They Appear

Recent updates

KYORIN Pharmaceutical's (TSE:4569) Soft Earnings Are Actually Better Than They Appear

Nov 14
KYORIN Pharmaceutical's (TSE:4569) Soft Earnings Are Actually Better Than They Appear

Shareholder Returns

4569JP PharmaceuticalsJP Market
7D-0.4%-0.1%-1.5%
1Y-18.2%10.6%13.7%

Return vs Industry: 4569 underperformed the JP Pharmaceuticals industry which returned 10.6% over the past year.

Return vs Market: 4569 underperformed the JP Market which returned 13.7% over the past year.

Price Volatility

Is 4569's price volatile compared to industry and market?
4569 volatility
4569 Average Weekly Movement2.0%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement3.6%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 4569 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 4569's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19232,042Yutaka Ogiharawww.kyorin-pharm.co.jp

KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Lyfuna for cough treatment; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex and Mometasone KYORIN, which are used as allergic rhinitis therapeutic agents; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug. It also provides Mucodyne, a mucoregulating drug; Montelukast KM, a drug for the treatment of bronchial asthma and allergic rhinitis; GeneSoC, a real-time PCR system; Rubysta, a disinfectant cleaner; Milton, a disinfectant; over-the-counter drugs; prescription medicines and quasi-drugs, diagnostics, and industrial chemicals; and reagents, intermediates, and other products.

KYORIN Pharmaceutical Co., Ltd. Fundamentals Summary

How do KYORIN Pharmaceutical's earnings and revenue compare to its market cap?
4569 fundamental statistics
Market capJP¥83.13b
Earnings (TTM)JP¥4.82b
Revenue (TTM)JP¥119.73b

17.2x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4569 income statement (TTM)
RevenueJP¥119.73b
Cost of RevenueJP¥68.41b
Gross ProfitJP¥51.33b
Other ExpensesJP¥46.51b
EarningsJP¥4.82b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)83.90
Gross Margin42.87%
Net Profit Margin4.03%
Debt/Equity Ratio18.9%

How did 4569 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

38%

Payout Ratio

Does 4569 pay a reliable dividends?

See 4569 dividend history and benchmarks
When do you need to buy 4569 by to receive an upcoming dividend?
KYORIN Pharmaceutical dividend dates
Ex Dividend DateMar 28 2025
Dividend Pay DateJun 05 2025
Days until Ex dividend96 days
Days until Dividend pay date165 days

Does 4569 pay a reliable dividends?

See 4569 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

KYORIN Pharmaceutical Co., Ltd. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.
Hidemaru YamaguchiCitigroup Inc